Azenta (AZTA) Other Non-Current Assets (2010 - 2026)
Azenta (AZTA) posted quarterly Other Non-Current Assets of $145.5 million for Q1 2026, up 60.48% year-over-year from $90.7 million in Q1 2025, and up 92.01% quarter-over-quarter from $75.8 million in Q4 2025.
Azenta (AZTA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Other Non-Current Assets for 17 consecutive years, with $145.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 60.48% year-over-year to $145.5 million; the TTM figure through Mar 2026 stood at $145.5 million (up 60.48% YoY), while the FY2025 annual figure was $75.8 million, changed N/A from the prior year.
- Other Non-Current Assets climbed to $145.5 million in Q1 2026 per AZTA's latest filing, from $75.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $542.2 million in Q3 2023 and bottomed at $23000.0 in Q1 2023.
- Historically, Other Non-Current Assets has averaged $99.3 million across 5 years, with a median of $75.8 million in 2025.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 99.86% — and 2024, when it jumped 44052.17%.
- Azenta's Other Non-Current Assets stood at $75.0 million in 2022, then rose by 2.95% to $77.2 million in 2023, then climbed by 7.84% to $83.2 million in 2024, then retreated by 8.93% to $75.8 million in 2025, then surged by 92.01% to $145.5 million in 2026.
- Business Quant data shows AZTA's Other Non-Current Assets at $145.5 million in Q1 2026, $75.8 million in Q4 2025, and $73.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | 148.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 148.08 Mn |
| Mar 31, 2026 | 145.55 Mn |
| Dec 31, 2025 | 75.80 Mn |
| Sep 30, 2025 | 73.54 Mn |
| Jun 30, 2025 | 162.50 Mn |
| Mar 31, 2025 | 90.70 Mn |
| Dec 31, 2024 | 83.24 Mn |
| Sep 30, 2024 | 23.63 Mn |
| Jun 30, 2024 | 77.03 Mn |
| Mar 31, 2024 | 10.16 Mn |
| Dec 31, 2023 | 77.19 Mn |
| Sep 30, 2023 | 542.15 Mn |
| Jun 30, 2023 | 623,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 74.98 Mn |
| Sep 30, 2022 | 181.48 Mn |
| Jun 30, 2022 | 53.30 Mn |
| Mar 31, 2022 | 16.76 Mn |
| Dec 31, 2021 | 15.02 Mn |
| Sep 30, 2021 | 311.39 Mn |